Last reviewed: June 18, 2026 Last updated: June 18, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
doi: 10.1517/14656566.2013.838559 66 ChristensenMMiossecPLarsenBDWernerUKnopFK
Retatrutide targets three metabolic pathways
Many of our patients are already seeing transformative results with these medications
By persistently activating GLP-1 receptors, these drugs provide a constant signal of fullness to the brain, leading to a significant reduction in calorie intake and subsequent weight loss
How It Helps Adults With Obesity In clinical studies, orforglipron produced dose-dependent reductions in body weight, with the highest doses delivering the strongest effects